Ehingen

Germany

1 total trials

Filter these 1 trials by phase, condition, sponsor and more.

Open in Search →

Combination of Abemaciclib and endocrine therapy in hormone receptor positive HER2 negative locally advanced or metastatic breast cancer wit … Ended recruitment

2024-511209-49-00 6 2022-04-26 Patients with hormone receptor positive HER2 negative locally advanced

Showing 1–1 of 1 trials